In Breast Cancer

CIRG focuses on pivotal strategies of development for new therapeutics.  Over 9,000 patients have been accrued into studies involving chemotherapy, hormonal therapy, supportive therapy, novel biologic agents, and translational research.

>>> Click on the study number for more details <<<